About the Pharmaceutical Industry

Over the years pharmaceutical companies have continuously come up with new drugs to control and treat diseases as well as mitigate patients’ suffering. New diseases, however, have also continuously been identified. Therefore, IPMG members are committed to finding new drugs to treat them.

According to the Ministry of Health data in 2013, there were 206 pharmaceutical companies operating in Indonesia. The national average annual growth in prescription drugs sales is estimated at 12%-13%. 

Today, Indonesia’s pharmaceutical market value is estimated at USD 6.24 billion, reflecting pharmaceutical spend of USD 26 per capita per annum, with national companies controlling 75% of the market share. Ethical drugs contributed 55%, or USD 3.2 billion, to the total market, while the over-the-counter drugs made up the remaining 41%, or USD 2.2 billion.

However, the country’s ethical drugs industry is expected to see a decline in sales next year as more people will be turning to generics under the National Health Insurance (JKN) scheme, a government program which promoted the prescription of generic medicines. Another contributing factor is the expected increase in production cost due to the fact that 95% of raw materials are still imported.

In 2015, the country’s pharmaceutical sales-to-GDP ratio is forecasted to shrink to 0.57% despite an expected increase in pharmaceutical sales to USD 6.89 billion from USD 6.18 billion in 2014.  Pharmaceutical sales per capita is estimated to go up to USD 26.9 billion in 2015 from USD 24.5 billion in 2014. The pharmaceutical sales-to-health spending ratio is predicted to drop from USD 21.4 billion in 2014 to USD 20.5 billion next year.


Other Health Data


IPMG is a member of :

News Highlights
Adisti Sukma Sawitri -- thejakartapost.com -- 31 August 2015
thejakartapost.com/Agence France-Presse -- 26 August 2015
Khoirul Amin -- thejakartapost.com -- 26 August 2015
thejakartapost.com -- 26 August 2015
thejakartaglobe.com -- 26 August 2015
thejakartapost.com/PRNewswire -- 31 August 2015
Sydney - US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: NVGN) today confirmed its comprehensive scientific review has identified high value opportunities for its ground-breaking technology platforms in areas of unmet patient need. Novogen is moving as quickly as practicable through the remaining preclinical projects prior to entering into Phase 1 clinical trials with our 3 lead compounds. More »
thejakartapost.com/PRNewswire -- 31 August 2015
 Hayward, California and Shanghai - MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced positive top-line results from the first Phase 2 clinical study for its lead drug candidate MRX-I. MRX-I is an oral oxazolidinone antibiotic designed to treat drug-resistant bacteria such as MRSA and VRE, while offering physicians and patients a safer and better tolerated therapeutic option than currently available oxazolidinone agents.

More »
thejakartapost.com/PRNewswire -- 31 August 2015
Jinan, China - DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading global provider of kidney care services, today announced it is forming a joint venture kidney care specialty hospital chain in Shandong province China. The agreement establishes DaVita (Shandong) Kidney Disease Hospital Co., Ltd., a first-of-its-kind renal dialysis joint venture between a multinational health care provider and the private sector in China. More »
thejakartapost.com/PRNewswire -- 31 August 2015
Albany, New York - AMRI (NASDAQ: AMRI) and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived active pharmaceutical ingredients, (“APIs”). 
The collaboration combines Saneca’s strength in extracting opiates from plant biomass and their expertise in developing and manufacturing controlled substance APIs with AMRI’s U.S. assets and their ability to tech transfer processes into these facilities. The collaboration will also capitalize on AMRI’s sales and marketing strength in the U.S. market.
More »
thejakartapost.com -- 28 August 2015
A group of children staged a demonstration at the Hotel Indonesia roundabout in Central Jakarta on Friday, calling on President Joko “Jokowi” Widodo to protect them and their fellow Indonesian children from tobacco. The young protesters also urged the government to respect the Framework Convention on Tobacco Control (FCTC), which the country has yet to sign. More »
March 2019

Copyright © 2013 International Pharmaceutical Manufacturers Group